Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report
Martina Pecoraro(Sapienza University of Rome), Valeria Panebianco(Sapienza University of Rome), Emanuele Messina(Policlinico Umberto I), Giuseppe Simone(Istituti di Ricovero e Cura a Carattere Scientifico), Costantino Leonardo(Policlinico Umberto I), Enrico Cortesi(Sapienza University of Rome), Francesco Del Giudice(Sapienza University of Rome), Rocco Simone Flammia(National Cancer Institute), Fabio Massimo Magliocca(Policlinico Umberto I), Ettore De Berardinis(Policlinico Umberto I)
Cited by 75
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618